Introduction
============

Body Mass Index (BMI) is widely used as a diagnostic measurement of obesity which in turn is related to various diseases such as heart disease, Type 2 diabetes, hypertension, and osteoarthritis [@ref-17]. Because of the important role BMI plays, numerous genome-wide association studies (GWAS) have been conducted to identify BMI-associated single nucleotide polymorphisms (SNPs). From these studies, researchers have identified several significant genes found to be related to BMI such as *FTO*, *BDNF*, and *MC4R*, among others ([@ref-9]; [@ref-12]; [@ref-21]). Further replication studies across various populations have also reported significant associations between these genes and BMI ([@ref-3]; [@ref-15]; [@ref-16]). Using these results, several studies have developed prediction models for BMI and obesity among various ethnic groups ([@ref-1]; [@ref-11]; [@ref-19]).

Although several BMI or obesity prediction models have been developed, these models have not been applicable to the Korean population. One issue is the significant genetic difference between the Korean population and other populations. The significance of many BMI-associated SNPs in GWAS conducted on other populations have not been replicated in the Korean population. Moreover, although SNPs in the prediction models have shown significant associations with BMI, the effective size difference of these prediction models are unsuitable for the Korean population. These results suggest a need for new BMI prediction methods that can be applied to the Korean population.

There are several methods for predicting specific diseases or clinical traits using multiple loci. The weighted genetic risk score (wGRS) is one simple and effective method for constructing SNP sets integrating the multiplied risk allele number of each SNP with the regression coefficient. Several previous studies have shown the effectiveness of using the wGRS to build a prediction model for various diseases ([@ref-6]; [@ref-18]; [@ref-22]).

In the present study, we aimed to identify BMI-associated SNPs for the Korean population using genotype data obtained from the Korea Association Resource (KARE) ([@ref-7]). To increase the validity of the study, we used the significant SNPs identified in previous BMI-related GWA-studies. Furthermore, we conducted SNP selection based on 10-fold cross validation used in conjunction with the wGRS on a SNP selection set consisting of 5,410 samples from Korean subjects. The wGRS of the selected SNPs was applied to an independent validation set consisting of 601 samples.

Method
======

Study subjects
--------------

The genotype data used in the present study were obtained from the KARE project ([@ref-7]). This study approved by Public Institutional Bioethics Committee designated by the Ministry of Health and Welfare (P01-201502-31-002). To ensure data quality, we eliminated samples and SNPs with a call rate of less than 98%. SNPs with a MAF of less than 0.05 were also excluded from our data set. A total of 6,011 samples (2,903 male and 3,108 female) were used for statistical analyses. The 6,011 samples were divided into one set of 5,410 samples (2,613 male and 2,797 female) to be used as a SNP selection set for 10-fold cross-validation and one set of 601 samples (290 male and 311 female) to be used as a validation set. The G\*Power Version 3.1 software (Universität Kiel, Germany) ([@ref-8]) was used to calculate statistical powers. The software found both the test set (*n* = 541) and validation set (*n* = 601) to be at over 95%. Details on the number of samples are summarized in [Table S1](#supp-1){ref-type="supplementary-material"}.

SNP pruning for statistical analyses
------------------------------------

In order to identify reliable SNPs for BMI prediction, we first identified the significant SNPs reported in prior BMI-related GWAS which had been validated by at least one secondary replication study. Then, we obtained the genotype data for the collected GWAS markers including other markers from nearby regions (±10 kb from the GWAS markers) from the KARE data (10,568 SNPs). To avoid the issue of high linkage disequilibrium (LD) found in the wGRS method, the LD coefficients (*r*^2^ \> 0.2) of all pairs of SNPs were calculated using the Haploview software ([@ref-2]). Finally, we obtained a set of 193 SNPs which showed significant relationships with BMI in the previous GWA-studies. We also identified SNPs in the regions near the reported SNPs. The *P*-values obtained from regression analyses conducted on the training set (*n* = 4, 869) were used to identify the most significant SNPs. The regression analysis was conducted using the GoldenHelix SVS8 software (Bozeman, MT, USA).

SNP selection for BMI prediction
--------------------------------

From the SNP selection set (5,410 samples), 10-fold cross validation was conducted on the genotype data (training set of 4,869 subjects and test set of 541 subjects) to identify the SNPs to be used for BMI prediction. The natural log-transformed BMI values were used for statistical analyses. SNPs were selected as tagging SNPs for each training set only where their *P*-value was less than 0.05 and where they were identified to be significant SNPs with the same LD. The wGRS was calculated as the sum of the number of BMI-increasing alleles multiplied by the regression slope across all variants in each set as previously described ($\documentclass[12pt]{minimal}
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}{}${\mathop{\sum }\nolimits }_{i=1}^{n}Number of risk allele in SNP\mathrm{i} \times \text{Weighti}$\end{document}$; *n* = number of SNP, Weight: regression slope value of SNP~*i*~) ([@ref-11]). Then, we divided the wGRS of each set into five sections in a subject number-dependent manner and calculated the average BMI values of the sections to obtain the trend lines. After 10-fold cross validation, we selected nine SNPs which overlapped across all training sets ([Table S2](#supp-1){ref-type="supplementary-material"}). Detailed information and analysis of the selected SNPs are detailed in [Table 1](#table-1){ref-type="table"} and [Fig. 1](#fig-1){ref-type="fig"}, respectively. The application process of wGRS using the selected nine SNPs to the independent validation set was the same as described above. The overall *P*-values for the trend lines were calculated using GraphPad Software (La Jolla, CA, USA) for all BMI values of each wGRS section.
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###### Results of regression analysis and allele information using SNP selection set including additionally constructed sets.
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                                                                                                                 *P*-values         Allele information   Genotype Count with BMI average                                                                                                                                     
  ------------------------------------------------------------------ ---------------- ------------- ------------ ------------------ -------------------- --------------------------------- --- --- ------ --------------- --------------- --------------- ------------------------------------------------------------------ -----------
  *[rs12566985](http://www.ncbi.nlm.nih.gov/snp/?term=rs12566985)*   *FPGT- TNNI3K*   1:74536509    Intron       0.001 − 0.03       2.00 × 10^−10^       G                                 A   G   0.11   4,260 (3.197)   1,061 (3.187)   89 (3.169)      --                                                                 [@ref-9]
  *[rs6545809](http://www.ncbi.nlm.nih.gov/snp/?term=rs6545809)*     *ADCY3*          2:24903846    Intron       0.002 − 0.02       6.00 × 10^−9^        T                                 T   C   0.44   1,705 (3.191)   2,660 (3.193)   1,045 (3.204)   *[rs10182181](http://www.ncbi.nlm.nih.gov/snp/?term=rs10182181)*   [@ref-12]
  *[rs2943634](http://www.ncbi.nlm.nih.gov/snp/?term=rs2943634)*     --               2:226203364   Intergenic   0.0002 − 0.02      2.00 × 10^−14^       C                                 A   C   0.08   4,577 (3.197)   805 (3.182)     28 (3.184)      --                                                                 [@ref-13]
  *[rs734597](http://www.ncbi.nlm.nih.gov/snp/?term=rs734597)*       --               6:50868566    Intergenic   0.0007 − 0.04      3.00 × 10^−20^       A                                 A   G   0.19   3,547 (3.192)   1,680 (3.199)   183 (3.202)     *[rs987237](http://www.ncbi.nlm.nih.gov/snp/?term=rs987237)*       [@ref-21]
  *[rs11030104](http://www.ncbi.nlm.nih.gov/snp/?term=rs11030104)*   *BDNF*           11:27662970   Intron       0.0004 − 0.006     5.00 × 10^−19^       A                                 G   A   0.45   1,617 (3.200)   2,708 (3.195)   1,085 (3.184)   --                                                                 [@ref-12]
  *[rs7988412](http://www.ncbi.nlm.nih.gov/snp/?term=rs7988412)*     *GTF3A*          13:27426145   Intron       0.001 − 0.02       2.00 × 10^−7^        T                                 T   C   0.13   4,053 (3.192)   1,275 (3.203)   82 (3.197)      *[rs12016871](http://www.ncbi.nlm.nih.gov/snp/?term=rs12016871)*   [@ref-12]
  *[rs2241423](http://www.ncbi.nlm.nih.gov/snp/?term=rs2241423)*     *MAP2K5*         15:67794500   Intron       0.008 − 0.04       1.00 × 10^−18^       G                                 G   A   0.37   2,162 (3.192)   2,508 (3.193)   740 (3.205)     --                                                                 [@ref-21]
  *[rs7202116](http://www.ncbi.nlm.nih.gov/snp/?term=rs7202116)*     *FTO*            16:53787703   Intron       0.00004 − 0.0006   2.00 × 10^−10^       G                                 G   A   0.13   4,143 (3.191)   1,162 (3.206)   105 (3.202)     --                                                                 [@ref-25]
  *[rs6567160](http://www.ncbi.nlm.nih.gov/snp/?term=rs6567160)*     --               18:60161902   Intergenic   0.00006 − 0.002    5.00 × 10^−30^       C                                 C   T   0.24   3,101 (3.190)   1,979 (3.198)   330 (3.212)     --                                                                 [@ref-12]

**Notes.**

Gene name and location and position of the SNPs were obtained from the NCBI database. The *P*-values were calculated using logistic regression on the SNP selection set as well as on the additional re-constructed sets (10 sets). Hyphens(--) Indicate that there was no data available or it was not applicable. C/C, C/R, and R/R represent the homozygote of the major allele, and the heterozygote and homozygote of the minor allele, respectively.

The SNPs in the LD column are those reported in previous GWAS and were used in the present studyBMIBody Mass IndexMAFMinor allele frequencyLDLinkage Disequilibrium
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Results
=======

The average age and average BMI values were slightly higher among female subjects than male subjects across the complete set of samples, the SNP selection set, and the validation set. Detailed information of the subjects is given in [Fig. 1](#fig-1){ref-type="fig"} and [Table S1](#supp-1){ref-type="supplementary-material"}.

An analysis flow chart for the present study is displayed in [Fig. 1](#fig-1){ref-type="fig"}. The results of each set of 10-fold cross-validations show that the BMI values increased in all training sets and corresponding test sets with respect to wGRS for *P*-values of \<0.0005 and *R*^2^ of \>0.2. The detailed *P*-values of the SNPs and BMI trend lines for the training set and test set are detailed in [Table S2](#supp-1){ref-type="supplementary-material"} and [Fig. S1](#fig-1){ref-type="fig"}, respectively.

Of the 28 SNPs applied to the cross-validation process, we selected only nine SNPs which overlapped across all 10-fold cross-validations conducted for BMI prediction. The nine SNPs are listed in [Table 1](#table-1){ref-type="table"} with their location, allele information, and genotype data as obtained from the SNP selection set. We calculated the wGRS using the nine SNPs based on the SNP selection set (*n* = 5, 410) and applied the wGRS to final validation set (*n* = 601). As expected, the results of the SNP selection set showed upward BMI trends across all three groups with *P*-values of 0.002 for the complete set, 0.01 for males, and 0.008 for females, respectively (data not shown).

To confirm the upward BMI trends and significance of SNPs, we randomly re-constructed an additional nine sets which had the same SNP selection set size (*n* = 5, 410) and final validation set size (*n* = 601). The results showed that the nine SNPs were significantly related to BMI across all additionally created sets (*P* \< 0.05). The detailed range of *P*-values is listed in [Table 1](#table-1){ref-type="table"}. The standard curves for the SNP selection sets also showed significant association with BMI (*P* \< 0.0001) with *R*^2^ values of 0.9729 for the complete set, 0.9296 for males, and 0.9598 for females ([Fig. 2](#fig-2){ref-type="fig"}).

![Analysis results applying the wGRS of the nine selected SNPs to the SNP selection set and to the final validation set.\
The BMI trends of each analysis group are displayed using their standard curve with the overall *P*-values and *R*^2^. The black closed and punctured circles represent the BMI values of each wGRS section in the SNP selection and validation set, respectively. The black and red dashed lines are the standard curves for the SNP selection and validation set. (A) BMI trends of SNP selection set and validation set using total subjects. (B) BMI trends of SNP selection set and validation set using male samples. (C) BMI trends of SNP selection set and validation set using female samples.](peerj-05-3510-g002){#fig-2}

Application results of the wGRS to the final validation sets showed increasing trends with a *P*-value of \<0.0001 and *R*^2^ value of 0.6766 ([Fig. 2A](#fig-2){ref-type="fig"}). This trend was also observed in the analyses for male (*P*-value of \<0.0001 with *R*^2^ of 0.5359) and female populations (*P*-value of \<0.0001 with *R*^2^ of 0.4632) ([Figs. 2B](#fig-2){ref-type="fig"} and [2C](#fig-2){ref-type="fig"}).

Discussion
==========

After the first large-scale GWAS was conducted using the KARE data with respect to several clinical traits ([@ref-7]), numerous follow-up studies have also been performed on independent cohorts. Of these studies, one reported that one SNP (*[rs17178527](http://www.ncbi.nlm.nih.gov/snp/?term=rs17178527)* in *LOC729076*) was found to be significantly associated with BMI after applying Bonferroni correction with a *P*-value of 1.45 × 10^−7^ ([@ref-1]). Several SNPs across various genes including *FTO*, *BDNF*, and *MC4R* were also found to be associated with BMI. Additional replication studies have consistently confirmed the significance of these SNPs in genes ([@ref-5]; [@ref-4]; [@ref-10]).

In the present study, we aimed to identify BMI-related SNPs using the KARE data in order to build a SNP set for BMI prediction. It is widely accepted that the influence of SNPs on BMI is small. Therefore, our study focused on increase of validity of using SNPs to understand BMI. We applied the wGRS to various test sets including validation sets and consistently found an increase in BMI trends. The *R*^2^-values of the standard curves in the final validations (\>0.4) suggest that the nine selected SNPs were not perfect indicators of BMI, but were significant enough to be considered for BMI prediction within the Korean population. Our results also indicated that the selected markers were not only associated to BMI within other populations but also within the Korean population.

There have been only a few studies conducted on BMI and/or obesity prediction in adulthood. We sought to find whether the 9 SNPs used in our models had been included in previous studies. From our research, we found that *[rs2241423](http://www.ncbi.nlm.nih.gov/snp/?term=rs2241423)* in *MAK2K5* had been selected as one of SNPs for an obesity model for Caucasian populations ([@ref-11]). In addition, *[rs11030104](http://www.ncbi.nlm.nih.gov/snp/?term=rs11030104)* in *BDNF* had been used in one study for BMI prediction within Korean populations ([@ref-1]). Two other *BDNF* SNPs (*[rs6265](http://www.ncbi.nlm.nih.gov/snp/?term=rs6265)* and *[rs4923461](http://www.ncbi.nlm.nih.gov/snp/?term=rs4923461)*) had been used in prediction models and had been found to be in high LD (*r*^2^ \> 0.8) with *[rs11030104](http://www.ncbi.nlm.nih.gov/snp/?term=rs11030104)*. Similarly, SNPs in *FTO* (*[rs9939609](http://www.ncbi.nlm.nih.gov/snp/?term=rs9939609)* or *[rs3751812](http://www.ncbi.nlm.nih.gov/snp/?term=rs3751812)*, *r*^2^ \> 0.8) and *ADCY3* (*[rs6545814](http://www.ncbi.nlm.nih.gov/snp/?term=rs6545814)* or *[rs10182181](http://www.ncbi.nlm.nih.gov/snp/?term=rs10182181)*, *r*^2^ \> 0.8) were used in other models ([@ref-1]; [@ref-11]; [@ref-20]). These results serve as evidence to support the validity of our results. In addition, comparison of two studies conducted on Korean populations suggest that at least 3 SNPs (*[rs11030104](http://www.ncbi.nlm.nih.gov/snp/?term=rs11030104)* in *BDNF, [rs6545814](http://www.ncbi.nlm.nih.gov/snp/?term=rs6545814)* in *ADCY3*, and *[rs9939609](http://www.ncbi.nlm.nih.gov/snp/?term=rs9939609)* in *FTO*) might play crucial roles in BMI prediction for Korean populations.

There have been numerous reports which showing significant associations between BMI and SNPs in *BDNF*, *ADCY3*, and *FTO*. The functional role of several SNPs of various genes have also been revealed. Of the three SNPs *[rs11030104](http://www.ncbi.nlm.nih.gov/snp/?term=rs11030104)*, *[rs6545814](http://www.ncbi.nlm.nih.gov/snp/?term=rs6545814)*, and *[rs9939609](http://www.ncbi.nlm.nih.gov/snp/?term=rs9939609)* which had been selected in both previous and the present study using Korean populations, *[rs11030104](http://www.ncbi.nlm.nih.gov/snp/?term=rs11030104)* in *BDNF* was found to influence eating behavior, causing lower satiety responsiveness in children ([@ref-14]). In addition, a previous meta-analysis reported that *[rs6545814](http://www.ncbi.nlm.nih.gov/snp/?term=rs6545814)* in *ADCY3* was associated with BMI in East Asian populations ([@ref-23]). Although the functional role of *[rs6545814](http://www.ncbi.nlm.nih.gov/snp/?term=rs6545814)* in BMI has not yet been fully demonstrated, one bioinformatics study reported that *[rs6545814](http://www.ncbi.nlm.nih.gov/snp/?term=rs6545814)* was an expression quantitative trait loci of the *ADCY3* gene ([@ref-26]). Further, it was demonstrated that *[rs9939609](http://www.ncbi.nlm.nih.gov/snp/?term=rs9939609)* in *FTO* had an impact on weight stabilization ([@ref-24]).

One limitation in this study is that there is no further confirmation from other independent subjects. To rectify this limitation, we set aside 601 samples from the total 6,011 samples as a final validation set. Because of this limitation, this study could not identify specific markers for the Korean population, a step which would require additional validation sets. Future studies to build a more appropriate BMI prediction model using Korean-specific markers should be considered.

In summary, we identified nine BMI-related SNPs in a Korean population using the KARE data. Our results showed upward BMI trends across the samples using a 10-fold cross validation process. Application of our BMI prediction set to a final validation set showed a similar increasing BMI trend when using the wGRS. Although our study has some limitation as described above, the results from the present study might be useful for further BMI-related research.
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###### Supplementary Figure 1

BMI trends of training sets and test sets. Each set was constructed using only 5,410 samples (4,869 for the training sets and 541 for the test sets). The overall *P*-values and *R*^2^ of each trend line are displayed. The black circle and red punctured circle represent the BMI values for the training set and test set, respectively, using 10-fold cross-validation. The black and red dashed lines are the standard curves for the complete training set and test set. (A) BMI trends of training set and test set using all samples. (B) BMI trends of training set and test set using male samples. (C) BMI trends of training set and test set using female samples.
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###### Genotype data (training set) of reported and nearby SNPs
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